source
- US lawmakers probe Chinese clinical trial sites for potential military links involving major drugmakersA bipartisan group of U.S. lawmakers has launched a national‑security investigation into whether several large pharmaceutical companies participated in clinical trials at Chinese sites that may hav…
- Unicycive Therapeutics receives second FDA complete response letter for kidney drug amid manufacturing problemsUnicycive Therapeutics' chronic kidney disease drug, a phosphate binder called oxylanthanum carbonate (OLC), has been rejected by the U.S. Food and Drug Administration for a second time. The FDA c…